Zobrazeno 1 - 8
of 8
pro vyhledávání: '"F A, Arabia"'
Publikováno v:
Surgical technology international. 2
The total artificial heart (TAH) is a device that fully replaces the failing heart and provides control of the circulatory system. This device has been used to provide permanent support, however, its most important role is to serve as a bridge to car
Autor:
Peer M. Portner, Klaus Affeld, Tofy Mussivand, F. A. Arabia, Victor L. Poirier, Patrick M. McCarthy, R. T. V. Kung
Publikováno v:
ASAIO Journal. 43:230-236
Autor:
F A, Arabia, J G, Copeland, R G, Smith, G K, Sethi, D A, Arzouman, A, Pavie, D, Duveau, W J, Keon, R, Masters, B, Foy, M, Carrier, W, Dembitsky, J, Long, R, Kormos
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
As the number of potential heart donors remains constant and the number of potential recipients continuous to increase, the need for circulatory devices to bridge patients becomes more important. The CardioWest total artificial heart (TAH) is a pneum
Autor:
J G, Copeland, A, Pavie, D, Duveau, W J, Keon, R, Masters, R, Pifarre, R G, Smith, F A, Arabia
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 15(1 Pt 1)
After reapproval by the Food and Drug Administration of the CardioWest total artificial heart for clinical investigation, an international study was started in January 1993 to ascertain the safety and efficacy of this device for bridging to heart tra
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 14(6 Pt 1)
Routine surveillance endomyocardial biopsies to diagnose unsuspected rejection are performed at 3- to 12-month intervals after heart transplantation. From 1979 to 1989, surveillance biopsies were routinely performed as a part of the yearly evaluation
Correlation of clinical embolic events with coagulability in a patient with a total artificial heart
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 14(5)
A 46-year-old female patient was supported for 185 days with a total artificial heart, underwent successful transplantation, and survived for over 1 year with no clinical residual findings suggestive of embolic events. Daily observation, analysis of
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 106(5)
Various devices that can be inserted transvenously to close an ostium secundum atrial septal defect are undergoing clinical trials. Although these are safe and effective in most instances, they may occasionally dislodge or fail to "button" properly,
Autor:
Gohar S; From the Division of Cardiothoracic Transplant and Assist Devices, Baylor College of Medicine, Houston, TX.; Department of Cardiopulmonary Transplantation and the Center for Cardiac Support, Texas Heart Institute, Houston, TX., Taimeh ZA; From the Division of Cardiothoracic Transplant and Assist Devices, Baylor College of Medicine, Houston, TX.; Department of Cardiopulmonary Transplantation and the Center for Cardiac Support, Texas Heart Institute, Houston, TX., Morgan JA; From the Division of Cardiothoracic Transplant and Assist Devices, Baylor College of Medicine, Houston, TX.; Department of Cardiopulmonary Transplantation and the Center for Cardiac Support, Texas Heart Institute, Houston, TX., Frazier OH; From the Division of Cardiothoracic Transplant and Assist Devices, Baylor College of Medicine, Houston, TX.; Department of Cardiopulmonary Transplantation and the Center for Cardiac Support, Texas Heart Institute, Houston, TX., A Arabia F; the Mechanical Circulatory Support Program, Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, CA., Civitello AB; From the Division of Cardiothoracic Transplant and Assist Devices, Baylor College of Medicine, Houston, TX.; Department of Cardiopulmonary Transplantation and the Center for Cardiac Support, Texas Heart Institute, Houston, TX., Nair AP; From the Division of Cardiothoracic Transplant and Assist Devices, Baylor College of Medicine, Houston, TX.; Department of Cardiopulmonary Transplantation and the Center for Cardiac Support, Texas Heart Institute, Houston, TX.
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2018 Jul/Aug; Vol. 64 (4), pp. e75-e77.